A middle-aged man with a troubled liver: Combination therapy in advanced (BCLC Stage C) hepatocellular carcinoma

A middle-aged man with a troubled liver: Combination therapy in advanced (BCLC Stage C) hepatocellular carcinoma

Advanced hepatocellular carcinoma carries a bad prognosis with a survival of only few months. Barcelona Clinic Liver Cancer (BCLC) Guidelines recommended sorafenib monotherapy as the treatment modality for advanced BCLC Stage C disease, citing a two-month increase in survival rates. Here, we highli...

Full description

Bibliographic Details
Main Authors: Zamri Zuhdi, Azlanuddin Azman, Affirul Chairil Ariffin, Razman Jarmin, Hairol Azrin Othman
Format: Article
Language:English
Published: GESDAV 2018-03-01
Series:Archives of Clinical and Experimental Surgery
Subjects:
Hepatocellular carcinoma
sorafenib
hepatectomy
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=243853

Similar Items

Similar Items